Quantum BioPharma Ltd. Increase Decrease In Cash And Cash Equivalents
Quantum BioPharma Ltd. (QNTM) reported Increase Decrease In Cash And Cash Equivalents of -$4.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-26
CAD
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|
| 2019-12-31 | -13.20M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 16.39M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.46M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $407.78K derived: sum of 2 quarters · filed 2026-03-26 | -$4.09M 20-F · filed 2026-03-26 | |
| 2025-09-30 | -$1.05M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$5.55M 6-K · filed 2025-11-06 | ||
| 2025-06-30 | -$4.50M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $2.88M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $2.69M derived: sum of 2 quarters · filed 2026-03-26 | $3.24M 20-F · filed 2026-03-26 | |
| 2024-09-30 | -$186.41K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $363.19K 6-K · filed 2025-11-06 | ||
| 2024-06-30 | $549.60K 6-K · filed 2025-08-07 | |||
| 2023-12-31 | -$14.22M 20-F · filed 2026-03-26 | |||
| 2022-12-31 | -$18.28M 20-F · filed 2023-03-31 | |||
| 2021-12-31 | $17.73M 20-F · filed 2023-03-31 | |||
| 2020-12-31 | $11.56M 20-F · filed 2023-03-31 | |||
| 2019-12-31 | -$9.93M 40-F · filed 2021-03-17 |